it has been suggested that there are as many as three or four CNPase polypeptides in the mouse Partial amino-acid and early nucleotide sequences from various species suggested that there was a single CNPase message transcribed from a simple gene of just three exons [2] . More recently a fourth exon (exon 0) has been described after the discovery of a second and shorter CNPase cDNA in mice [3] . This additional exon encodes an initiator methionine only and therefore it has been suggested that an alternative splicing mechanism may operate for the CNPase gene [3] . Transcription of exons 1-3 would result in a long message encoding CNPI, whereas inclusion of exon 0 and its splicing 60 bp upstream of exon I gives a shorter CNPII mRNA. Such CNPase transcripts would differ only at their 5' ends and would make use of alternative initiation codons from exons 1 and 0, respectively. The smaller CNPII message, with its shorter 5' end, would make use of the upstream initiation codon and therefore encodes a polypeptide with an additional 20 amino acids at its amino-terminal end.
Antibodies have been produced now that can dis- tinguish between the CNPI and CNPII polypeptides [4, 51, confirming the difference at their amino terminus. Being predominantly basic, this N-terminal extension could explain the more basic migration of rabbit-brain CNPII on 2-dimensional gel electrophoresis [6] , as well as providing the cyclic AMP-dependent phosphorylation site specific to CNPII in rabbit-brain myelin [6] . It is of some importance therefore to establish whether this alternative splicing mechanism operates within the CNPase genes of other species.
In the human a single CNPase gene has been identified on chromosome 17 by somatic-cell hybrid studies [7- 91 and has been localized further to band 17q21 by in situ hybridization analysis [7, 81. This gene spans 9 kb, has four exons and has a sequence [8] identical in all but one base to that described previously for the human cDNA [lo] . Of the various human CNPase cDNAs isolated so far [8, 101 only two contain considerable 5' non-coding sequence and both represent CNPII-type mRNAs, that is, a transcript spliced from all four human CNPase exons. There has been no evidence as yet for a human CNPI mRNA and the existence of only a single message is supported by Northern-blot analysis, where a single CNPase-mRNA band of 3 kb has been observed in human-brain RNA [lo] .
In the present study we have identified the transcriptional start site of the human CNPII-type mFWA ( Figure 1 ). Primers complementary to sequences both within exons 0 and 1 gave reversetranscription products ending 87, 88, 89 and 90 bp upstream of the initiation codon in exon 0. This start site 30-33 bp downstream of the TATA box previously identified in the human CNPase gene [8] , corresponds almost exactly with the mouse CNPII cDNA transcriptional start site [ 3 ] . How Primers on either side of the exon 1 splice site (Figure 1 ) have been used to amplify a CNPImRNA PCR product of the correct size and restriction map, from both human-brain total RNA and from a human-brain cDNA library. This message is produced by means of a second CNPase promoter within intron 1. Exon 0 and the splice site 60 bp upstream of exon 1 are unused, so that the 5' end of the CNPI mRNA is encoded by intron 1 sequence.
In the human the CNPI promoter elements remain to be found, although the primer-extension studies mentioned above suggest a start site 300-400 bp upstream of exon 1. It is intriguing that, like the mouse messages, the human mRNAs for CNPI and CNPII appear to have 5' ends varying by 200-300
bp and yet this size difference is not apparent from Northern-blot studies. Further analysis is required to establish the full length of these human CNPase mRNAs, as it remains a possibility that these messages differ at their 3' ends also and are, in fact, of similar size. . Scintillant was added and the radioactivity was measured. Specificity of binding was measured using unlabelled fMI,P.
